TIMI Risk Score for STEMI
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Very Low Risk0–0
- Low Risk1–1
- Low Risk2–2
- Low-Intermediate Risk3–3
The TIMI Risk Score for STEMI calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include age. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates 30-day mortality in ST-elevation MI using 8 clinical variables (0-14 points). Derived from the InTIME II trial; helps risk-stratify STEMI patients at presentation.
Clinical Indication
The TIMI Risk Score for STEMI is indicated for bedside clinical practice to support Estimates 30-day mortality in ST-elevation MI using 8 clinical variables (0-14 points). Derived from the InTIME II trial; helps risk-stratify STEMI patients at presentation.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.
TIMI-STEMI = age_pts(0/2/3) + history(1) + hypotension(3) + tachycardia(2) + killip(2) + low_weight(1) + anterior(1) + late_treatment(1)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient's age in years (65-74 = 2 points, >= 75 = 3 points)(years) |
| history_dm_htn_angina | boolean | Yes | History of diabetes, hypertension, or angina (1 point if any present) |
| sbp | number | Yes | Systolic blood pressure on presentation in mmHg (< 100 = 3 points)(mmHg) |
| heart_rate | number | Yes | Heart rate on presentation in beats per minute (> 100 = 2 points)(bpm) |
| killip_class | string | Yes | Killip classification of heart failure (II-IV = 2 points) |
| weight_kg | number | Yes | Body weight in kg (< 67 kg = 1 point)(kg) |
| anterior_ste_or_lbbb | boolean | Yes | Anterior ST elevation or left bundle branch block on ECG (1 point) |
| time_to_treatment_hours | number | Yes | Time from symptom onset to treatment in hours (> 4 h = 1 point)(hours) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Very Low Risk | 30-day mortality: 0.8% |
| 1–1 | Low Risk | 30-day mortality: 1.6% |
| 2–2 | Low Risk | 30-day mortality: 2.2% |
| 3–3 | Low-Intermediate Risk | 30-day mortality: 4.4% |
| 4–4 | Intermediate Risk | 30-day mortality: 7.3% |
| 5–5 | Intermediate-High Risk | 30-day mortality: 12.4% |
| 6–7 | High Risk | 30-day mortality: 16.1-23.4% |
| 8–14 | Very High Risk | 30-day mortality: 27.4-35.9% |
Evidence-Based References (EBM)
- Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation. 2000;102(17):2031-2037.